FATE THERAPEUTICS INC (FATE)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch FATE
Latest sale
$95k
Aug 4 · Unusual
Form 4 sales
140
On record
Form 144 notices
16
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleNo plan
    Aug 4 2025

    Sold 14,466 shares at $1.06 ($15k)

    Valamehr Bahram, President and CEO

    No 10b5-1 planSold 4.1% of holdings ($370k position)334,898 shares leftFiling

  2. 2 Form 4 saleNo plan
    Aug 4 same day

    Sold 9,037 shares at $1.06 ($10k)

    Tahl Cindy, Officer

    No 10b5-1 planSold 2.2% of holdings ($431k position)397,670 shares left0.8x usual sizeFiling

  3. 3 Form 4 saleNo plan
    Jan 9 +158 days

    Sold 5,190 shares at $1.07 ($6k)

    Valamehr Bahram, President and CEO

    No 10b5-1 planSold 1.5% of holdings ($358k position)329,708 shares leftFiling

  4. 4 Form 4 saleNo plan
    Jan 9 same day

    Sold 10,589 shares at $1.06 ($11k)

    Tahl Cindy, Officer

    No 10b5-1 planSold 2.7% of holdings ($422k position)387,081 shares leftFiling

  5. 5 Form 4 saleUnusual
    May 20 +131 days

    Sold 28,946 shares at $1.88 ($54k)

    Valamehr Bahram, President and CEO

    No 10b5-1 planSold 4.4% of holdings ($1.2M position)635,762 shares left3.3x usual sizeFiling

  6. 6 Form 4 saleNo plan
    May 20 same day

    Sold 25,590 shares at $1.88 ($48k)

    Tahl Cindy, Officer

    No 10b5-1 planSold 3.9% of holdings ($1.2M position)628,155 shares left2.8x usual sizeFiling

  7. 7 Form 4 saleUnusual
    Aug 4 +76 days

    Sold 43,947 shares at $2.46 ($108k)

    Valamehr Bahram, President and CEO

    No 10b5-1 planSold 6.9% of holdings ($1.6M position)591,815 shares left3.8x usual sizeFiling

  8. 8 Form 4 saleUnusual
    Aug 4 same day

    Sold 38,800 shares at $2.46 ($95k)

    Tahl Cindy, Officer

    No 10b5-1 planSold 6.2% of holdings ($1.5M position)589,355 shares left4x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (156)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for FATE
Source
Aug 4, 2026Tahl CindyOfficerForm 4 sale38,800$95k6.2%UnusualSEC
Aug 4, 2026Valamehr BahramPresident and CEOForm 4 sale43,947$108k6.9%UnusualSEC
May 20, 2026Tahl CindyOfficerForm 4 sale25,590$48k3.9%No planSEC
May 20, 2026Valamehr BahramPresident and CEOForm 4 sale28,946$54k4.4%UnusualSEC
Jan 9, 2026Tahl CindyOfficerForm 4 sale10,589$11k2.7%No planSEC
Jan 9, 2026Valamehr BahramPresident and CEOForm 4 sale5,190$6k1.5%No planSEC
Aug 4, 2025Tahl CindyOfficerForm 4 sale9,037$10k2.2%No planSEC
Aug 4, 2025Valamehr BahramPresident and CEOForm 4 sale14,466$15k4.1%No planSEC
Jan 10, 2025Bressi Jerome CharlesOfficerForm 4 sale5,980$9k2.2%No planSEC
Jan 10, 2025Tahl CindyOfficerForm 4 sale5,654$9k1.7%No planSEC
Jan 10, 2025Valamehr BahramPresident and CEOForm 4 sale8,705$13k2.4%No planSEC
Dec 20, 2024Green JeremyDirector, 10% ownerForm 4 sale341,633$574k2.7%No planSEC
Dec 20, 2024Redmile Group, LLCDirector, 10% StockholderForm 144 notice341,633$567kNoticeSEC
Aug 6, 2024Xu YuanDirectorForm 4 sale633$3k6.8%RoutineSEC
Mar 4, 2024Dulac Edward J IIIChief Financial OfficerForm 4 sale2,447$19k2.4%RoutineSEC
Jan 29, 2024Dulac Edward J IIIChief Financial OfficerForm 4 sale1,849$9k1.7%RoutineSEC
Jan 29, 2024Dulac Edward J IIIOfficerForm 144 notice1,849$9kNoticeSEC
Jan 9, 2024Tahl CindyGeneral Counsel and SecretaryForm 4 sale10,874$48k7.1%No planSEC
Jan 9, 2024Valamehr BahramChief R&D OfficerForm 4 sale11,271$49k6.7%No planSEC
Jan 9, 2024Wolchko J ScottPresident and CEOForm 4 sale14,391$63k3.7%No planSEC
Jan 9, 2024Dulac Edward J IIIChief Financial OfficerForm 4 sale7,028$31k6.2%No planSEC
Jan 9, 2024Wolchko J ScottOfficer, DirectorForm 144 notice14,391$63kNoticeSEC
Jan 9, 2024Dulac Edward J IIIOfficerForm 144 notice7,028$31kNoticeSEC
Jan 9, 2024Tahl CindyOfficerForm 144 notice10,874$47kNoticeSEC
Jan 9, 2024Valamehr BahramOfficerForm 144 notice11,271$49kNoticeSEC
Jan 2, 2024Dulac Edward J IIIChief Financial OfficerForm 4 sale5,182$19k4.4%RoutineSEC
Jan 2, 2024Dulac Edward J IIIOfficerForm 144 notice5,182$19kNoticeSEC
Dec 18, 2023Dulac Edward J IIIChief Financial OfficerForm 4 sale1,585$6k1.3%RoutineSEC
Dec 18, 2023Dulac Edward J IIIOfficerForm 144 notice1,585$6kNoticeSEC
Nov 9, 2023Tahl CindyGeneral Counsel and SecretaryForm 4 sale24,363$58k13.7%RoutineSEC
Nov 9, 2023Tahl CindyOfficerForm 144 notice24,363$58kNoticeSEC
Aug 18, 2023Dulac Edward J IIIChief Financial OfficerForm 4 sale4,718$13k3.8%No planSEC
Aug 18, 2023Dulac Edward J IIIOfficerForm 144 notice4,718$13kNoticeSEC
Aug 4, 2023Xu YuanDirectorForm 4 sale632$2k6.4%RoutineSEC
Aug 4, 2023Xu YuanDirectorForm 144 notice632$2kNoticeSEC
Jul 5, 2023Powl Brian T.Chief Commercial OfficerForm 4 sale3,854$19k8.6%No planSEC
Jul 5, 2023Dulac Edward J IIIChief Financial OfficerForm 4 sale5,182$25k4.0%RoutineSEC
Jul 5, 2023Powl Brian T.OfficerForm 144 notice3,854$19kNoticeSEC
Jul 5, 2023Dulac Edward J IIIOfficerForm 144 notice5,182$25kNoticeSEC
Jun 14, 2023Xu YuanDirectorForm 4 sale3,460$19k25.8%RoutineSEC
Jun 14, 2023Xu YuanDirectorForm 144 notice3,460$19kNoticeSEC
Apr 18, 2023Chu Yu-WayeChief Medical OfficerForm 4 sale2,532$17k1.8%RoutineSEC
Apr 18, 2023Chu Yu-WayeOfficerForm 144 notice2,532$17kNoticeSEC
Apr 14, 2023Green JeremyDirector, 10% ownerForm 4 sale302,339$1.8M2.3%No planSEC
Apr 14, 2023Redmile Capital Offshore Fund (ERISA), Ltd.Director,10% StockholderForm 144 notice135,134$758kNoticeSEC
Jan 10, 2023Wolchko J ScottPresident and CEOForm 4 sale45,907$241k10.6%Plan not statedSEC
Jan 10, 2023Valamehr BahramChief R&D OfficerForm 4 sale10,917$57k6.1%Plan not statedSEC
Jan 10, 2023Tahl CindyGeneral Counsel and SecretaryForm 4 sale11,553$61k6.1%Plan not statedSEC
Jan 10, 2023Plavsic MarkChief Technical OfficerForm 4 sale3,418$18k2.7%Plan not statedSEC
Jan 10, 2023Dulac Edward J IIIChief Financial OfficerForm 4 sale7,331$38k5.4%Plan not statedSEC
Jan 10, 2023Chu Yu-WayeChief Medical OfficerForm 4 sale7,825$41k5.2%Plan not statedSEC
Aug 18, 2022Dulac Edward J IIIChief Financial OfficerForm 4 sale5,135$153k3.6%Plan not statedSEC
Jul 22, 2022Wolchko J ScottPresident and CEOForm 4 sale36,246$1.2M7.7%Plan not statedSEC
Jul 7, 2022Valamehr BahramChief R&D OfficerForm 4 sale17,158$519k8.7%Plan not statedSEC
Jul 6, 2022Valamehr BahramChief R&D OfficerForm 4 sale7,842$236k4.2%Plan not statedSEC
Jul 5, 2022Plavsic MarkChief Technical OfficerForm 4 sale3,719$92k2.8%Plan not statedSEC
Jun 7, 2022Agarwal ShefaliDirectorForm 4 sale841$18k31.4%UnusualSEC
Jun 3, 2022Mendlein JohnDirectorForm 4 sale1,364$31k0.9%Plan not statedSEC
Jun 3, 2022Jooss KarinDirectorForm 4 sale1,483$34k55.3%UnusualSEC
Jun 3, 2022Hershberg RobertDirectorForm 4 sale672$15k25.1%UnusualSEC
Jun 3, 2022Coughlin TimothyDirectorForm 4 sale1,439$33k2.4%Plan not statedSEC
Jun 3, 2022Agarwal ShefaliDirectorForm 4 sale807$18k30.1%UnusualSEC
Jun 1, 2022Tahl CindyGeneral Counsel and SecretaryForm 4 sale25,000$574k11.7%Plan not statedSEC
Apr 22, 2022Wolchko J ScottPresident and CEOForm 4 sale40,000$1.4M8.5%Plan not statedSEC
Apr 19, 2022Chu Yu-WayeChief Medical OfficerForm 4 sale4,062$144k2.6%Plan not statedSEC
Apr 1, 2022Tahl CindyGeneral Counsel and SecretaryForm 4 sale25,000$971k11.7%Plan not statedSEC
Mar 14, 2022Valamehr BahramChief R&D OfficerForm 4 sale25,000$777k12.2%Plan not statedSEC
Mar 10, 2022Mendlein JohnDirectorForm 4 sale31,562$1.1M16.5%Plan not statedSEC
Jan 21, 2022Wolchko J ScottPresident and CEOForm 4 sale40,000$1.6M8.5%Plan not statedSEC
Jan 11, 2022Wolchko J ScottPresident and CEOForm 4 sale14,566$709k3.3%Plan not statedSEC
Jan 11, 2022Tahl CindyGeneral Counsel and SecretaryForm 4 sale5,419$263k3.4%Plan not statedSEC
Jan 11, 2022Valamehr BahramChief R&D OfficerForm 4 sale4,570$222k3.0%Plan not statedSEC
Jan 11, 2022Dulac Edward J IIIChief Financial OfficerForm 4 sale1,770$86k1.6%Plan not statedSEC
Jan 11, 2022Chu Yu-WayeSenior VP Clinical DevelopmentForm 4 sale3,965$192k3.2%Plan not statedSEC
Jan 10, 2022Wolchko J ScottPresident and CEOForm 4 sale34,156$1.6M7.1%Plan not statedSEC
Jan 10, 2022Tahl CindyGeneral Counsel and SecretaryForm 4 sale7,738$359k4.6%Plan not statedSEC
Jan 10, 2022Valamehr BahramChief R&D OfficerForm 4 sale5,596$260k3.6%Plan not statedSEC
Jan 3, 2022Tahl CindyGeneral Counsel and SecretaryForm 4 sale50,000$3M22.8%Plan not statedSEC
Dec 20, 2021Dulac Edward J IIIChief Financial OfficerForm 4 sale15,977$959k12.6%Plan not statedSEC
Dec 13, 2021Valamehr BahramChief R&D OfficerForm 4 sale25,000$1.2M13.8%Plan not statedSEC
Dec 10, 2021Chu Yu-WayeSenior VP Clinical DevelopmentForm 4 sale7,500$386k5.6%Plan not statedSEC
Nov 18, 2021Wolchko J ScottPresident and CEOForm 4 sale20,000$1.1M4.8%Plan not statedSEC
Oct 22, 2021Wolchko J ScottPresident and CEOForm 4 sale60,000$3.6M13.2%Plan not statedSEC
Oct 1, 2021Tahl CindyGeneral Counsel and SecretaryForm 4 sale50,000$2.9M31.6%UnusualSEC
Sep 28, 2021Dulac Edward J IIIChief Financial OfficerForm 4 sale19,460$1.2M27.1%UnusualSEC
Sep 13, 2021Valamehr BahramChief Development OfficerForm 4 sale25,000$1.7M20.7%Plan not statedSEC
Aug 19, 2021Wolchko J ScottPresident and CEOForm 4 sale20,000$1.8M4.8%Plan not statedSEC
Aug 19, 2021Dulac Edward J IIIChief Financial OfficerForm 4 sale3,474$307k6.0%Plan not statedSEC
Jul 23, 2021Wolchko J ScottPresident and CEOForm 4 sale60,000$5.1M13.2%Plan not statedSEC
Jul 1, 2021Tahl CindyGeneral Counsel and SecretaryForm 4 sale55,534$4.7M33.9%UnusualSEC
Jun 14, 2021Valamehr BahramChief Development OfficerForm 4 sale25,000$2.2M20.7%Plan not statedSEC
May 20, 2021Wolchko J ScottPresident and CEOForm 4 sale20,000$1.5M4.8%Plan not statedSEC
Apr 23, 2021Wolchko J ScottPresident and CEOForm 4 sale60,000$5.1M13.2%Plan not statedSEC
Apr 16, 2021Chu Yu-WayeSenior VP Clinical DevelopmentForm 4 sale3,275$273k4.8%Plan not statedSEC
Apr 1, 2021Tahl CindyOfficerForm 4 sale30,000$2.5M21.7%Plan not statedSEC
Mar 15, 2021Valamehr BahramChief Development OfficerForm 4 sale25,000$2.3M20.7%Plan not statedSEC
Mar 8, 2021Shoemaker Daniel DChief Scientific OfficerForm 4 sale25,000$2M25.5%UnusualSEC
Feb 18, 2021Wolchko J ScottPresident and CEOForm 4 sale20,000$2M4.8%Plan not statedSEC
Jan 22, 2021Wolchko J ScottPresident and CEOForm 4 sale60,000$6M13.2%Plan not statedSEC
Jan 19, 2021Tahl CindyGeneral Counsel and SecretaryForm 4 sale35,000$4M28.0%UnusualSEC
Jan 11, 2021Wolchko J ScottPresident and CEOForm 4 sale69,407$8.1M16.5%UnusualSEC
Jan 11, 2021Valamehr BahramChief Development OfficerForm 4 sale9,484$1.1M10.9%Plan not statedSEC
Jan 11, 2021Tahl CindyGeneral Counsel and SecretaryForm 4 sale9,483$1.1M9.5%Plan not statedSEC
Jan 11, 2021Shoemaker Daniel DChief Scientific OfficerForm 4 sale9,482$1.1M10.2%Plan not statedSEC
Dec 17, 2020Wolchko J ScottPresident and CEOForm 4 sale20,000$1.8M4.5%Plan not statedSEC
Dec 14, 2020Valamehr BahramChief Development OfficerForm 4 sale25,000$2.4M22.3%UnusualSEC
Nov 16, 2020Shoemaker Daniel DChief Scientific OfficerForm 4 sale25,000$1.3M21.2%Plan not statedSEC
Nov 13, 2020Wolchko J ScottPresident and CEOForm 4 sale60,000$3.1M12.5%Plan not statedSEC
Nov 5, 2020Tahl CindyGeneral Counsel and SecretaryForm 4 sale70,801$3.6M41.6%UnusualSEC
Oct 16, 2020Tahl CindyGeneral Counsel and SecretaryForm 4 sale29,199$1.5M22.7%Plan not statedSEC
Oct 1, 2020Tahl CindyGeneral Counsel and SecretaryForm 4 sale35,000$1.4M26.0%UnusualSEC
Sep 14, 2020Valamehr BahramChief Development OfficerForm 4 sale25,000$907k22.3%Plan not statedSEC
Sep 14, 2020Shoemaker Daniel DChief Scientific OfficerForm 4 sale25,000$908k17.5%Plan not statedSEC
Jan 30, 2020Wolchko J ScottPresident and CEOForm 4 sale25,000$636k5.6%Plan not statedSEC
Jan 8, 2020Valamehr BahramChief Development OfficerForm 4 sale5,700$118k6.2%Plan not statedSEC
Jan 8, 2020Tahl CindyGeneral Counsel and SecretaryForm 4 sale5,700$118k5.4%Plan not statedSEC
Jan 8, 2020Shoemaker Daniel DChief Scientific OfficerForm 4 sale5,700$118k3.8%Plan not statedSEC
Dec 30, 2019Shoemaker Daniel DChief Scientific OfficerForm 4 sale25,000$487k16.8%Plan not statedSEC
Dec 20, 2019Wolchko J ScottPresident and CEOForm 4 sale50,000$1M12.4%Plan not statedSEC
Oct 15, 2019Wolchko J ScottPresident and CEOForm 4 sale21,017$303k5.6%Plan not statedSEC
Oct 15, 2019Valamehr BahramChief Development OfficerForm 4 sale6,200$88k8.5%Plan not statedSEC
Oct 15, 2019Tahl CindyGeneral Counsel and SecretaryForm 4 sale10,200$145k11.3%Plan not statedSEC
Oct 15, 2019Shoemaker Daniel DChief Scientific OfficerForm 4 sale11,800$169k8.7%Plan not statedSEC
Aug 1, 2019Nashat AmirDirectorForm 4 sale62,005$1.4M84.9%UnusualSEC
Jul 30, 2019Nashat AmirDirectorForm 4 sale118,333$2.7M91.0%UnusualSEC
Jul 24, 2019Nashat AmirDirectorForm 4 sale81,899$1.8M86.5%UnusualSEC
Jul 22, 2019Nashat AmirDirectorForm 4 sale71,166$1.6M84.0%UnusualSEC
Jun 27, 2019Shoemaker Daniel DChief Scientific OfficerForm 4 sale12,500$253k8.4%Plan not statedSEC
May 16, 2019Wolchko J ScottPresident and CEOForm 4 sale14,335$278k3.7%Plan not statedSEC
Apr 18, 2019Wolchko J ScottPresident and CEOForm 4 sale20,000$322k5.1%Plan not statedSEC
Mar 28, 2019Shoemaker Daniel DChief Scientific OfficerForm 4 sale12,500$212k8.4%Plan not statedSEC
Mar 21, 2019Wolchko J ScottPresident and CEOForm 4 sale20,000$352k5.1%Plan not statedSEC
Mar 1, 2019Tahl CindyGeneral Counsel and SecretaryForm 4 sale25,000$404k21.7%Plan not statedSEC
Feb 25, 2019Tahl CindyGeneral Counsel and SecretaryForm 4 sale25,000$402k21.7%Plan not statedSEC
Jan 30, 2019Nashat AmirDirectorForm 4 sale53,017$751k3.5%Plan not statedSEC
Jan 29, 2019Nashat AmirDirectorForm 4 sale97,500$1.4M6.0%Plan not statedSEC
Jan 28, 2019Nashat AmirDirectorForm 4 sale70,000$965k4.1%Plan not statedSEC
Jan 25, 2019Nashat AmirDirectorForm 4 sale90,000$1.3M5.0%Plan not statedSEC
Jan 18, 2019Nashat AmirDirectorForm 4 sale39,483$643k2.2%Plan not statedSEC
Jan 7, 2019Tahl CindyGeneral Counsel and SecretaryForm 4 sale25,000$400k35.5%UnusualSEC
Dec 20, 2018Nashat AmirDirectorForm 4 sale33,474$410k1.8%Plan not statedSEC
Dec 19, 2018Nashat AmirDirectorForm 4 sale91,210$1.2M4.7%Plan not statedSEC
Dec 13, 2018Nashat AmirDirectorForm 4 sale17,788$297k0.9%Plan not statedSEC
Dec 12, 2018Nashat AmirDirectorForm 4 sale425,000$7.1M17.8%Plan not statedSEC
Dec 11, 2018Nashat AmirDirectorForm 4 sale82,528$1.4M3.3%Plan not statedSEC
Oct 16, 2017Wolchko J ScottPresident and CEOForm 4 sale17,168$67k12.1%Plan not statedSEC
Oct 16, 2017Tahl CindyGeneral Counsel and SecretaryForm 4 sale8,091$31k15.1%Plan not statedSEC
Oct 16, 2017Shoemaker Daniel DChief Scientific OfficerForm 4 sale13,225$51k12.7%Plan not statedSEC
Jun 12, 2014Flynn Peter DOfficerForm 4 sale6,488$45k61.6%UnusualSEC
Jun 10, 2014Flynn Peter DOfficerForm 4 sale3,305$23k45.0%UnusualSEC
May 1, 2014Flynn Peter DOfficerForm 4 sale9,793$69k64.5%UnusualSEC
Apr 4, 2014Flynn Peter DOfficerForm 4 sale5,889$47k46.7%UnusualSEC
Apr 2, 2014Weyer ChristianOfficer, DirectorForm 4 sale10,000$90k100.0%UnusualSEC
Apr 1, 2014Flynn Peter DOfficerForm 4 sale4,038$40k37.5%UnusualSEC
Apr 1, 2014Wolchko J ScottOfficerForm 4 sale20,000$193k57.1%UnusualSEC
Mar 31, 2014Shoemaker Daniel DChief Technology OfficerForm 4 sale8,653$85k25.0%Plan not statedSEC